Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Corbett

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
Science Translational Medicine|December 1, 2022
Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year laterEmma C Milligan, Katherine Olstad, Caitlin A Williams, et al.
ACS Medicinal Chemistry Letters|August 20, 2025
Peptidylarginine Deiminase (PAD) Inhibitor Optimization through Displacement of a Trapped Water MoleculeMark E Schnute, Gary M Chinigo, Kentaro Futatsugi, et al.
The Journal of Infectious Diseases|June 10, 2021
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics SummitMatthew D Hall, James M Anderson, Annaliesa Anderson, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2021
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variantsLingshu Wang, Tongqing Zhou, Yi Zhang, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2021
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airwayMatthew Gagne, Kizzmekia S Corbett, Barbara J Flynn, et al.
Emerging Infectious Diseases|July 5, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure among Evacuees from Wuhan, China, 2020Benjamin D Hallowell, Christina M Carlson, Jesica R Jacobs, et al.
Cell|December 18, 2021
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lungMatthew Gagne, Kizzmekia S Corbett, Barbara J Flynn, et al.
Biorxiv : the Preprint Server for Biology|June 2, 2021
Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman PrimatesKizzmekia S Corbett, Anne P Werner, Sarah O' Connell, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2020
LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infectionBryan E Jones, Patricia L Brown-Augsburger, Kizzmekia S Corbett, et al.
Nature Immunology|August 21, 2021
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primatesKizzmekia S Corbett, Anne P Werner, Sarah O' Connell, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Science Translational Medicine|December 1, 2022
Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year laterEmma C Milligan, Katherine Olstad, Caitlin A Williams, et al.
ACS Medicinal Chemistry Letters|August 20, 2025
Peptidylarginine Deiminase (PAD) Inhibitor Optimization through Displacement of a Trapped Water MoleculeMark E Schnute, Gary M Chinigo, Kentaro Futatsugi, et al.
The Journal of Infectious Diseases|June 10, 2021
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics SummitMatthew D Hall, James M Anderson, Annaliesa Anderson, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2021
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variantsLingshu Wang, Tongqing Zhou, Yi Zhang, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2021
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airwayMatthew Gagne, Kizzmekia S Corbett, Barbara J Flynn, et al.
Emerging Infectious Diseases|July 5, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure among Evacuees from Wuhan, China, 2020Benjamin D Hallowell, Christina M Carlson, Jesica R Jacobs, et al.
Cell|December 18, 2021
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lungMatthew Gagne, Kizzmekia S Corbett, Barbara J Flynn, et al.
Biorxiv : the Preprint Server for Biology|June 2, 2021
Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman PrimatesKizzmekia S Corbett, Anne P Werner, Sarah O' Connell, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2020
LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infectionBryan E Jones, Patricia L Brown-Augsburger, Kizzmekia S Corbett, et al.
Nature Immunology|August 21, 2021
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primatesKizzmekia S Corbett, Anne P Werner, Sarah O' Connell, et al.
Pageof 18